1. Home
  2. CNK vs STVN Comparison

CNK vs STVN Comparison

Compare CNK & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

HOLD

Current Price

$33.81

Market Cap

3.6B

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$17.71

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNK
STVN
Founded
1984
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Movies/Entertainment
Containers/Packaging
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.7B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
CNK
STVN
Price
$33.81
$17.71
Analyst Decision
Buy
Buy
Analyst Count
10
3
Target Price
$33.70
$25.67
AVG Volume (30 Days)
2.2M
320.1K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
1.24%
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,115,000,000.00
N/A
Revenue This Year
$11.01
$9.67
Revenue Next Year
$3.70
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
2.15
N/A
52 Week Low
$21.60
$12.89
52 Week High
$34.40
$28.00

Technical Indicators

Market Signals
Indicator
CNK
STVN
Relative Strength Index (RSI) 68.26 50.18
Support Level $25.11 $17.23
Resistance Level N/A $19.41
Average True Range (ATR) 1.27 0.88
MACD 0.27 -0.19
Stochastic Oscillator 89.59 36.29

Price Performance

Historical Comparison
CNK
STVN

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: